R&D

Data Science Company for Next Generation Drug Discovery

Menu

PLATFORM

Our platform solutions can be applied to drugs at any stage
: candidate substances to clinical drugs. We are open to all types of collaboration.

KMAP®

KMAP is NGS-based drug-induced transcriptome data for thousands of drugs & related analytics,
which provide deep & rich information on drug mode-of-action (MoA).
This big dataset has been optimized for our research goals and has value as a gold standard.

Composition

  • ~3,000 approved drugs (including US, EU, JP approvals)
  • 2 types of cell-lines
  • 3 concentrations

KMAP drug’s disease categories

KMAP drug’s target categories

KMAP Express™

KMAP Express™ is an integrated analysis platform for drug development mainly using transcriptome data.
It allows expanding potentials of a candidate molecule such as new indication discovery through understanding drug action and comprehensive interpretation.
ORDER
DOWNLOAD BROCHURE PDF
WEB PLATFORM